Loading clinical trials...
Loading clinical trials...
The purpose of this study is to assess the safety and efficacy of Adalimumab in uveitis.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Oregon Health and Science University
Collaborators
NCT07552012 · Active Non-anterior, Non-infectious Uveitis
NCT07218770 · Active Noninfectious Uveitis Affecting the Posterior Segment
NCT06974162 · Uveitis, Aqueous Humor, and more
NCT07145008 · Macular Edema (ME), Non Infectious Uveitis
NCT05486468 · Uveitis, Uveitis, Posterior, and more
Oregon Health & Science University
Portland, Oregon
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions